natgillin/translations-raw huggingface dataset:
Digoxin and lisinopril
Digoksin in liziniopril
Your doctor is now prescribing this medicine as an additional medicine to help control your blood sugar.
Zdravnik vam je predpisal to zdravilo kot dodatno zdravilo, ki vam bo pomagalo nadzorovati vrednosti vašega sladkorja v krvi.
• Store in packaging provided to protect from light until you are ready to prepare and use your dose.
• Zdravilo shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo, dokler niste pripravljeni za pripravo in injiciranje odmerka.
Unlike native GLP-1, prolongedrelease exenatide has a pharmacokinetic and pharmacodynamic profile in humans suitable for once weekly administration.
V nasprotju z nativnim GLP-1 ima eksenatid v obliki s podaljšanim sproščanjem tak farmakokinetični in farmakodinamični profil pri ljudeh, da je primeren za uporabo enkrat tedensko.
Ask your pharmacist how to safely throw away the container with used pens and needles.
Farmacevta vprašajte, kako varno zavreči vsebnik z uporabljenimi peresniki in iglami.
Prolonged-release exenatide that has been frozen must not be used.
Eksenatida v obliki s podaljšanim sproščanjem, ki je bil zamrznjen, ne smete uporabiti.
• Continue holding the pen upright to prevent the medicine from accidently leaking.
• Še naprej držite peresnik pokonci, da boste preprečili naključno iztekanje zdravila.
See Description of selected adverse reactions section, below.
Glejte Opis izbranih neželenih učinkov, spodaj.
1 Getting started
1 Začetek
One patient was reported with major hypoglycaemia since he had a low blood glucose value (2.2 mmol/l) and requested assistance with oral carbohydrate treatment which resolved the event.
Pri enem bolniku so poročali o hujši hipoglikemiji, saj je bila pri njem vrednost glukoze v krvi nizka (2,2 mmol/l) in je potreboval pomoč peroralnih ogljikovih hidratov, kar je rešilo stanje.
Keep this flap open so you can refer to it as you go through the steps
Zaščito pustite odprto, da boste lahko sledili, ko greste skozi opisane korake
Pharmacotherapeutic group: Drugs used in diabetes, glucagon-like peptide-1 (GLP-1) analogues, ATC code: A10BJ01.
Farmakoterapevtska skupina: Zdravila za zdravljenje diabetesa, analogi glukagonu podobnega peptida-1 (GLP-1), oznaka ATC: A10BJ01.
Press the top of the vial firmly into the orange connector.
Vrh viale močno pritisnite v oranžni povezovalec.
Bydureon BCise pen can be kept at room temperature for up to 4 weeks.
Peresnik Bydureon BCise je mogoče hraniti na sobni temperaturi do 4 tedne.
The mean dose of insulin glargine at the beginning of treatment was 10.1 IU/day rising to 31.1 IU/day for insulin glargine-treated patients.
Srednja vrednost odmerka insulina glargina na začetku zdravljenja je bila 10,1 i.e./dan in je narasla na 31,1 i.e./dan pri bolnikih, zdravljenih z insulinom glarginom.
Air bubbles are not a problem with this type of injection.
Zračni mehurčki pri takšni vrsti injiciranja niso problem.
− Needle is hidden.
− Igla je skrita.
You may use a biohazard container, another hard plastic container, or a metal container.
Uporabite lahko vsebnik za biološko nevarne odpadke, kakšen drug vsebnik iz trde plastike ali kovinski vsebnik.
Shake vigorously like you would shake a bottle of oil-and-vinegar salad dressing.
Močno stresajte, kot bi stresali steklenico s solatnim prelivom iz olja in kisa.
You should not use this medicine while breast-feeding.
Tega zdravila med dojenjem ne smete uporabljati.
Subsequent injections should use a different site of injection each week.
Mesto injiciranja nadaljnjih injekcij naj bo vsak teden različno.
During these next steps, you will be mixing the medicine and filling the syringe.
V naslednjih korakih boste mešali zdravilo in polnili injekcijsko brizgo.
Overall, the level of glycaemic control (HbA1c) in patients treated with Bydureon BCise with low titre antibodies at the last visit (-1.1% to -1.5%) was comparable to that observed in those without antibody titres (-1.1% to -1.4%).
Na splošno je bila raven urejenosti glikemije (HbA1c) pri bolnikih, ki so bili zdravljeni z zdravilom Bydureon BCise in so imeli ob zadnjem obisku nizke titre protiteles (-1,1 % do -1,5 %), primerljiva s tisto, opaženo pri bolnikih, ki niso imeli titrov protiteles (-1,1 % do -1,4 %).
Do not touch the orange connector inside.
Notranjega oranžnega povezovalca se ne dotikajte.
The pooled clinical studies data set for Bydureon BCise comprises two phase 3 comparator-controlled studies of 6 to 12 months duration.
Združeni podatki kliničnih študij za zdravilo Bydureon BCise obsegajo podatke dveh od 6- do 12-mesečnih kontroliranih študij 3. faze s primerjalno učinkovino.
B. Make sure you received your full dose.
B. Preverite, ali ste prejeli celotni odmerek.
Use a new pen for each injection.
Za vsako injiciranje uporabite nov peresnik.
D. Compare both sides of the mixing window to the photos below,
D. Primerjajte obe strani okenca za mešanje s spodnjimi fotografijami tako, da podržite peresnik ob strani.
If you lose weight too quickly (more than 1.5 kg per week) talk to your doctor about it since this may cause problems such as gallstones.
Če telesno maso izgubite prehitro (več kot 1,5 kg na teden), se o tem pogovorite z zdravnikom, ker to lahko povzroči težave, kot npr. žolčne kamne.
Subsequently, exenatide concentrations of approximately 153-208 pg/ml were maintained, indicating that steady state was achieved.
Po tem je koncentracija eksenatida ostala na približno 153-208 pg/ml, kar je znak, da je bilo doseženo stanje dinamičnega ravnovesja.
Bydureon BCise pen should be stored as follows:
Peresnik Bydureon BCise je treba shranjevati kot sledi:
The solvent should be visually inspected prior to use.
Vehikel je pred uporabo potrebno dobro vizualno pregledati.
Animal studies with exenatide did not indicate harmful effects with respect to fertility; high doses of exenatide caused skeletal effects and reduced foetal and neonatal growth.
Študije na živalih z eksenatidom niso pokazale neposrednih škodljivih učinkov na plodnost; veliki odmerki eksenatida so povzročili učinke na okostju in manjšo rast ploda in novorojenčka.
You will need a puncture-resistant container that is large enough to hold the entire pen.
Potrebovali boste vsebnik, odporen proti prebadanju, ki je dovolj velik, da drži celoten peresnik.
It will be easier to mix the medicine if the pen is at room temperature.
Zdravilo boste lažje premešali, če bo peresnik ogret na sobno temperaturo.
This medicine is provided as a powder and solvent (liquid) for suspension for injection in a pre-filled pen.
To zdravilo je na voljo kot prašek in vehikel (tekočina) za suspenzijo za injiciranje v napolnjenem injekcijskem peresniku.
You cannot save it for later use.
Ne morete ga shraniti za poznejšo uporabo.
- If you have severe problems with your stomach emptying (including gastroparesis) or food digestion, as the use of this medicine is not recommended.
- Če imate hude težave s praznjenjem želodca (vključno z gastroparezo) ali prebavo hrane, ker uporaba tega zdravila v tem primeru ni priporočljiva.
After the click, continue to hold the needle in your skin for 10 seconds.
Po kliku naj ostane igla v koži še 10 sekund.
The vital status was known at the end of the study for 98.9% and 98.8% of the patients in the prolonged-release exenatide and placebo group, respectively.
Vitalno stanje je bilo ob koncu študije znano za 98,9 % bolnikov v skupini z eksenatidom v obliki s podaljšanim sproščanjem in za 98,8 % bolnikov v skupini s placebom.
Hold the vial connector package.
Držite paket s povezovalcem viale.
• nausea (nausea is most common when starting this medicine, but decreases over time in most patients)
• slabost (slabost je najpogostejša na začetku zdravljenja s tem zdravilom, vendar se pri večini bolnikov sčasoma zmanjša)
Weight loss was sustained over 7 years in these patients.
Pri teh bolnikih je bila izguba telesne mase v 7 letih vzdrževana.
On average in the phase 3 studies, 12% of the patients had higher titre antibodies.
V študijah III. faze je imelo povprečno 12 % bolnikov visok titer protiteles.
Subsequently, exenatide concentrations of approximately 151-265 pg/ml were maintained indicating that steady state was achieved.
Po tem je koncentracija eksenatida ostala na približno 151-265 pg/ml, kar je znak, da je bilo doseženo stanje dinamičnega ravnovesja.
How soon to inject after mixing Mixing the medicine
Kako hitro po mešanju injicirati Mešanje zdravila
In addition, a double-blind, placebo-controlled cardiovascular outcome study (EXSCEL) enrolled 14,752 subjects with type 2 diabetes and any level of CV risk when added to the current usual care.
Poleg tega je dvojno slepa, s placebom kontrolirana študija srčno-žilnih izidov (EXSCEL) zajela 14.752 bolnikov s sladkorno boleznijo tipa 2 in kakršno koli ravnjo srčno-žilnega tveganja, po dodatku k trenutnemu običajnemu zdravljenju.
This will help you get the correct dose of medicine.
To vam bo pomagalo vzeti pravilen odmerek zdravila.
Prolonged-release exenatide should be administered once a week on the same day each week.
Eksenatid v obliki s podaljšanim sproščanjem se daje enkrat tedensko, na enak dan v tednu.
If you are not sure you have taken the full dose of Bydureon If you are not sure if you have taken all of your dose, do not inject another dose of this medicine, just take it next week as planned.
Če niste prepričani, ali ste vzeli celotni odmerek zdravila Bydureon Če niste prepričani, ali ste vzeli celotni odmerek, si ne injicirajte še enega.
The use of this medicinal product does not require additional self-monitoring.
Uporaba tega zdravila ne zahteva dodatnega bolnikovega samonadzora.
It may help to hold the pen up to the light to see in the window.
Pomaga lahko, če peresnik podržite proti svetlobi, da boste videli okence.
After you lift the pen from your skin, the green shield will move back up to lock over the needle.
Ko boste peresnik dvignili s kože, se bo zeleni ščitnik pomaknil nazaj navzgor in se bo zaskočil nad iglo.
In a proportion of these the glycaemic response to prolonged-release exenatide was absent at the end of the controlled period of studies; 2.6% of patients showed no glucose improvement with higher titre antibodies whereas 1.6% showed no improvement while antibody negative.
Pri deležu je bil glikemični odziv na eksenatid v obliki s podaljšanim sproščanjem ob koncu kontroliranih študij odsoten; 2,6 % bolnikov ni pokazalo izboljšanja glukoze z višjimi titri protiteles, 1,6 % bolnikov pa ni pokazalo izboljšanja, ko so bili negativni za protitelesa.
The primary safety (noninferiority) and efficacy (superiority) endpoint in EXSCEL was the time to first confirmed Major Adverse Cardiac Event (MACE): cardiovascular (CV)-related death, nonfatal myocardial infarction (MI) or nonfatal stroke.
Primarni opazovani dogodek varnosti (neinferiornost) in učinkovitosti (superiornost) v študiji EXSCEL je bil čas do prvega potrjenega hudega srčnega neželenega dogodka (MACE - Major Adverse Cardiac Event): smrti zaradi SŽ vzroka, miokardnega infarkta (MI) brez smrtnega izida ali možganske kapi brez smrtnega izida.
Connecting the parts
Povezovanje sestavnih delov
- If you lose weight too quickly (more than 1.5kg per week)talk to your doctor about it since this may cause problems such as gallstones.
- Če telesno maso izgubljate prehitro (več kot 1,5 kg na teden), se o tem pogovorite z zdravnikom, ker vam to lahko povzroči težave, kot npr. žolčne kamne.
Interaction with warfarin
Medsebojno delovanje z varfarinom
All patients with missing endpoint data are imputed as non-responders.
Vsi bolniki, ki niso imeli podatkov o opazovanem dogodku, so bili obravnavani kot neodzivni.
Do not go to the next step unless your medicine is mixed well.
Ne nadaljujte z naslednjim korakom, dokler zdravilo ni dobro premešano.
• skin reactions at the injection site following injection of exenatide.
• kožne reakcije na mestu injiciranja po injekciji eksenatida.
Fertility No fertility studies in humans have been conducted.
Plodnost Študij plodnosti pri ljudeh niso izvedli.
While patients with high titre antibodies at the last visit had an attenuated HbA1c response, HbA1c reductions in these patients were clinically relevant (-0.6% to -0.7%).
Bolniki z visokimi titri protiteles na zadnjem obisku so imeli sicer manjši odziv HbA1c, vendar so bila znižanja HbA1c pri teh bolnikih klinično pomembna (-0,6 % do -0,7 %).
• has a lid,
• ima pokrov,
The reduction in Cmax is of limited clinical relevance and no adjustment of dosing of oral contraceptives is required.
Znižanje Cmax ima majhno klinično pomembnost, zato prilagoditev odmerjanja peroralnih kontraceptivov ni potrebna.
Also read the Package Leaflet in your carton.
Preberite tudi Navodilo za uporabo, ki se nahaja v vaši škatli.
There are no adequate data from the use of prolonged-release exenatide in pregnant women.
O uporabi eksenatida v obliki s podaljšanim sproščanjem pri nosečih ženskah nimamo ustreznih podatkov.
C. Check the liquid, inside the inspection window.
C. Preverite tekočino skozi okence za ogled.
A. Let your pen warm up.
A. Pustite, da se peresnik ogreje.
• Do not use past the expiration date.
• Ne uporabljajte po datumu izteka roka uporabnosti.
Effects of overdoses with exenatide (based on immediate-release exenatide clinical studies) included severe nausea, severe vomiting and rapidly declining blood glucose concentrations.
Učinki prevelikega odmerjanja eksenatida (na osnovi kliničnih študij z eksenatidom v obliki s takojšnim sproščanjem) so vključevali hudo navzeo, hudo bruhanje in hitro padanje koncentracije glukoze v krvi.
D. Inject the medicine.
D. Injicirajte zdravilo.
Very common side effects (may affect more than 1 in 10 people) • hypoglycaemia (low blood sugar) when taken with a medicine that contains a sulphonylurea
Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov) • hipoglikemija (nizek krvni sladkor) v primeru uporabe z zdravilom, ki vsebuje sulfonilsečnino.
When you unscrew the orange cap, the green shield keeps the needle covered until you inject.
Ko odvijete oranžni pokrovček, zeleni ščitnik prekriva iglo, dokler ne injicirate zdravila.
The mean apparent volume of distribution of exenatide following subcutaneous administration of a single dose of exenatide is 28 l.
Povprečni navidezni volumen porazdelitve eksenatida po subkutanem dajanju enkratnega odmerka eksenatida je 28 l.
Why should I inject my medicine right away after mixing it?
Zakaj moram zdravilo injicirati takoj potem, ko ga premešam?
The air bubbles will not harm you or affect your dose.
Zračni mehurčki vam ne bodo škodovali ali vplivali na vaš odmerek.
If you see any clumps, keep tapping.
Če vidite grudice, trkajte naprej.
Be careful not to push in the plunger.
Pazite, da ne pritisnete na bat.
Put the covered needle down.
Odložite pokrito iglo.
This is what the syringe should now look like.
Tako mora sedaj izgledati injekcijska brizga.
The most common adverse events leading to withdrawal in either treatment group were nausea and vomiting.
Najpogostejša neželena učinka, ki sta vodila do prekinitve pri obeh zdravljenih skupinah, sta bila navzea in bruhanje.
A total of 14,752 patients were randomised 1:1 to either prolonged-release exenatide 2 mg once weekly or placebo, added to the current usual care which could include SGLT2 inhibitors.
Skupno 14.752 bolnikov so v razmerju 1:1 randomizirali ali na 2 mg eksenatida v obliki s podaljšanim sproščanjem enkrat na teden ali na placebo; eden ali drugi sta bila dodana trenutnemu običajnemu zdravljenju, ki je lahko vključevalo zaviralce SGLT2.
Patients (%) achieving
Bolniki (%), ki so dosegli
You may see white medicine along the sides, bottom or top.
Morda boste videli belo zdravilo ob straneh, na dnu ali na vrhu.
Ask your pharmacist how to safely throw it away.
S farmacevtom se posvetujte, kako ga varno zavreči.
EXSCEL was a pragmatic cardiovascular (CV) outcome study in patients with type 2 diabetes and any level of CV risk.
Študija EXSCEL je bila pragmatična študija srčno-žilnih (SŽ) izidov pri bolnikih s sladkorno boleznijo tipa 2 in kakršno koli ravnjo SŽ tveganja.
A. Combine the medicine.
A. Premešajte zdravilo.
It's normal if you see air bubbles in the liquid, and they will cause no harm.
Normalno je, če v tekočini vidite zračne mehurčke, saj vam ti ne bodo škodovali.
Amongst patients treated with Bydureon BCise evaluable for antibodies (N = 393), the incidence of potentially immunogenic injection site reactions (most commonly injection site nodule) during the two studies was approximately 20%.
Med bolniki, ki so bili zdravljeni z zdravilom Bydureon BCise in jih je bilo mogoče oceniti glede protiteles (N = 393), je bila pojavnost potencialno imunogenih reakcij na mestu injiciranja (najpogosteje nodul na mestu injiciranja) v teh dveh študijah približno 20 %.
Improvements in blood pressure were maintained through 52 weeks.
Izboljšanje krvnega tlaka je trajalo vseh 52 tednov.
Administration of the oral contraceptive 35 minutes after exenatide did not affect AUC but resulted in a reduction of the Cmax of ethinyl estradiol by 45%, and Cmax of levonorgestrel by 27-41%, and a delay in tmax by 2-4 h due to delayed gastric emptying.
Dajanje peroralnega kontraceptiva 35 minut po dajanju eksenatida ni vplivalo na AUC, vendar je povzročilo znižanje Cmax etinildiestrola za 45 % in Cmax levonorgestrela za 27-41 % ter zakasnitev tmax za 2-4 ure zaradi upočasnjenega praznjenja želodca.
ACS=acute coronary syndrome; CI=confidence interval; CV=cardiovascular; HF=heart failure; HR=hazard ratio; MACE=major adverse cardiac event; MI=myocardial infarction; n=number of patients with an event; N=number of patients in treatment group.
AKS = akutni koronarni sindrom, IZ = interval zaupanja, SŽ = srčno-žilen, SP = srčno popuščanje, ROg = razmerje ogroženosti, MACE = hud srčni neželen dogodek, MI = miokardni infarkt, n = število bolnikov z dogodkom, N = število bolnikov v terapevtski skupini.
The needle is attached to the pen and covered by the orange cap.
Igla je nameščena na peresnik in pokrita z oranžnim pokrovčkom.
This will allow enough time for all the medicine to go from the pen to under your skin.
Tako bo na voljo dovolj časa, da bo zdravilo v celoti prišlo iz peresnika pod kožo.
Holding the pen with the orange cap straight up helps prevent the medicine from leaking.
Pokončni položaj peresnika z oranžnim pokrovčkom naravnost navzgor pomaga preprečiti iztekanje zdravila.
A. Choose your injection site,
A. Izberite mesto za injiciranje,
It is not known if exenatide passes into your milk.
Ni znano, ali se eksenatid izloča v materino mleko.
The results of a study using paracetamol as a marker of gastric emptying suggest that the effect of prolonged-release exenatide to slow gastric emptying is minor and not expected to cause clinically significant reductions in the rate and extent of absorption of concomitantly administered oral medicinal products.
Rezultati študije, pri kateri so kot kazalec praznjenja želodca uporabili paracetamol, so pokazali, da je učinek eksenatida v obliki s podaljšanim sproščanjem na upočasnjeno praznjenje želodca minimalen in ni pričakovati, da bi povzročalo pomembne spremembe v hitrosti in obsegu absorpcije sočasno uporabljenih peroralnih zdravil.
• Hold the pen by the end with the orange label and tap the pen firmly against the palm of your hand.
• Držite peresnik na koncu z oranžno nalepko in z njim odločno potrkavajte ob dlan.
If you do not inject your medicine right away after mixing, the medicine may separate, and you will not get your full dose.
Če si zdravila ne injicirate takoj potem, ko ga premešate, se zdravilo lahko loči in ne boste dobili celotnega odmerka.
Administration of a combination oral contraceptive (30 mcg ethinyl estradiol plus 150 mcg levonorgestrel) one hour before immediate-release exenatide did not alter the AUC, Cmax or Cmin of either ethinyl estradiol or levonorgestrel.
Dajanje kombiniranega peroralnega kontraceptiva (30 μg etinilestradiola in 150 μg levonorgestrela) eno uro pred dajanjem eksenatida v obliki s takojšnim sproščanjem ni spremenilo AUC, Cmax ali Cmin etinilestradiola ali levonorgestrela.
To prevent a clogged needle, always mix the medicine very well, and inject immediately after mixing.
Da se izognete zamašeni igli, vedno dobro zmešajte zdravilo in ga injicirajte takoj po mešanju.
• Bydureon BCise pen • Alcohol swab • A clean, flat surface • Puncture-resistant container (see “disposal” instructions at the end of these instructions) STEP 1: Prepare for injection
• Peresnik Bydureon BCise • Alkoholni zloženec • Čista, vodoravna površina • vsebnik, odporen proti prebadanju (glejte navodila za odstranjevanje na koncu teh navodil)
What you need to know before you use Bydureon
Kaj morate vedeti, preden boste uporabili zdravilo Bydureon
Then choose a different injection site and finish taking the injection.
Nato izberite drugo mesto za injiciranje in dokončajte injiciranje.
When 1,000 mg paracetamol tablets were administered, either with or without a meal, following 14 weeks of prolonged-release exenatide therapy, no significant changes in paracetamol AUC were observed compared to the control period.
Ko so bolnikom po 14-tedenskem zdravljenju z eksenatidom v obliki s podaljšanim sproščanjem dali 1000 mg paracetamola, s hrano ali brez nje, niso opazili pomembnih sprememb v AUC v primerjavi s kontrolnim obdobjem.
International normalised ratio increased (see section
Preiskave zvišanje mednarodnega umerjenega razmerja (glejte poglavje 4.4)
Mean body weight (kg)
Povprečna telesna masa (kg)
If you do not inject Bydureon immediately, the medicine will start to form small clumps in the syringe.
Če zdravila Bydureon ne injicirate takoj, bodo v zdravilu začele nastajati grudice.
Each carton also contains one spare needle.
Vsaka škatla vsebuje tudi eno rezervno iglo.
Turn the knob from the Lock to the Unlock position until you hear a click.
Zasukajte gumb iz položaja "zaklenjeno" v položaj "odklenjeno", dokler ne zaslišite klika.
Be sure you are holding the pen at the end with the knob and the orange label.
Prepričajte se, da peresnik držite na koncu, na katerem sta gumb in oranžna nalepka.
Important information about some of the ingredients of Bydureon This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
Pomembne informacije o nekaterih sestavinah zdravila Bydureon Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni “brez natrija”.
How do I know that the medicine is mixed well?
Kako vem, da je zdravilo dobro premešano?
For instructions on the preparation of the medicinal product before administration, see section 6.6 and the “Instructions for the User”.
Za navodila o pripravi zdravila pred dajanjem glejte poglavje 6.6 in “Navodila za uporabnika”.
If you have questions about taking Bydureon
Če imate vprašanje o jemanju zdravila Bydureon
Consistent with the potentially immunogenic properties of protein and peptide pharmaceuticals, patients may develop antibodies to exenatide following treatment with prolonged-release exenatide.
V skladu z morebitno imunogenimi lastnostmi beljakovinskih in peptidnih učinkovin, lahko bolniki po zdravljenju z eksenatidom v obliki s podaljšanim sproščanjem razvijejo protitelesa proti eksenatidu.
Therefore, no dose adjustments for medicinal products sensitive to delayed gastric emptying are required.
Zato ni potrebe po spreminjanju odmerka zdravil, ki so občutljiva na zakasnjeno praznjenje želodca.
In addition, hypoglycaemia with a sulphonylurea occurred very commonly (see Description of selected adverse reactions, below).
Poleg tega se je med uporabo s sulfonilsečninami zelo pogosto pojavila hipoglikemija (glejte Opis izbranih neželenih učinkov, spodaj).
In clinical studies of Bydureon BCise, acute pancreatitis occurred in 0.4% of patients.
V kliničnih študijah z zdravilom Bydureon BCise se je akutni pankreatitis pojavil pri 0,4 % bolnikov.
What should I do if the top of the plunger has been pushed past the black dashed Dose Line?
Kaj naj naredim, če je bil bat potisnjen preko črne odmerne črte?
It is normal to see a few drops of medicine inside the orange cap after you unscrew it.
Normalno je, da v oranžnem pokrovčku vidite nekaj kapljic zdravila, potem ko pokrovček odvijete.
Placebo + Insulin glargine
Placebo + insulin glargin